Re: Pricing of weight-loss drugs I can't see a way it's doable unless prices are reduced probably in the 75% range. We have a start—at least for patients who pay out of pocket (#msg-175000157). Moreover, Ozempic/Wegovy will almost certainly be on Medicare’s IRA price-setting list for 2027.